Document:

Exhibit 10.6 - Series D Common Stock Purchase Warrant to MidTown Partners & Co.,
LLC dated May 6, 2005.

THIS WARRANT AND THE SHARES OF COMMON STOCK  ISSUABLE UPON EXERCISE  HEREOF HAVE
NOT  BEEN  REGISTERED  UNDER  THE  SECURITIES  ACT  OF  1933,  AS  AMENDED  (THE
"SECURITIES ACT") OR ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD,  TRANSFERRED
OR OTHERWISE  DISPOSED OF UNLESS  REGISTERED  UNDER THE SECURITIES ACT AND UNDER
APPLICABLE STATE SECURITIES LAWS OR PETCARE TELEVISION NETWORK,  INC. SHALL HAVE
RECEIVED  AN  OPINION  OF  COUNSEL  REASONABLY  SATISFACTORY  TO  MEDICAL  MEDIA
TELEVISION,  INC. THAT  REGISTRATION OF SUCH SECURITIES UNDER THE SECURITIES ACT
AND UNDER THE PROVISIONS OF APPLICABLE STATE SECURITIES LAWS IS NOT REQUIRED.

                   SERIES D COMMON STOCK PURCHASE WARRANT FOR

                             SHARES OF COMMON STOCK

                                       OF

                         MEDICAL MEDIA TELEVISION, INC.

                               Expires May 5, 2015

                                                        Number of Shares: 20,000
Date of Issuance: May 6, 2005                            Warrant No. 05-0605D-MP

         FOR VALUE  RECEIVED,  subject to the provisions  hereinafter set forth,
the undersigned, Medical Media Television, Inc., a Florida corporation (together
with its successors and assigns,  the "Issuer"),  hereby  certifies that Midtown
Partners & Co., LLC or its  registered  assigns is entitled to subscribe for and
purchase,  during  the Term (as  hereinafter  defined),  up to  Twenty  thousand
(20,000)  shares  (subject to  adjustment as  hereinafter  provided) of the duly
authorized,  validly issued,  fully paid and non-assessable  Common Stock of the
Issuer, at an exercise price per share of $2.40.  Capitalized terms used in this
Warrant and not  otherwise  defined  herein shall have the  respective  meanings
specified in Section 9 hereof.

         1. Term.  The term of this  Warrant  shall  commence on May 6, 2005 and
shall expire at 5:00 p.m.,  Eastern  Time, on May 5, 2015 (such period being the
"Term").

         2. Method of Exercise  Payment;  Issuance of New Warrant;  Transfer and
Exchange.

         (a) Time of Exercise.  The purchase rights  represented by this Warrant
may be exercised in whole or in part during the Term  commencing  on May 6, 2005
and expiring on May 5, 2015.

         (b) Method of Exercise. The Holder hereof may exercise this Warrant, in
whole or in part,  by the  surrender  of this Warrant  (with the  exercise  form
attached hereto duly executed) at the principal office of the Issuer, and by the
payment  to the  Issuer  of an  amount of  consideration  therefor  equal to the
Warrant Price,  payable at such Holder's  election by certified or official bank
check or by wire transfer to an account designated by the Issuer.

         (c) Exercise  Price.  The  Exercise  Price of this Warrant is $2.40 per
share.

<PAGE>

         (d) Issuance of Stock Certificates. In the event of any exercise of the
rights  represented by this Warrant in accordance  with and subject to the terms
and  conditions  hereof,  (i)  certificates  for the shares of Warrant  Stock so
purchased  shall be dated the date of such  exercise and delivered to the Holder
hereof within a reasonable time, not exceeding three (3) Trading Days after such
exercise and the Holder hereof shall be deemed for all purposes to be the holder
of the shares of Warrant Stock so purchased as of the date of such exercise and,
unless this Warrant has expired, a new Warrant representing the number of shares
of Warrant Stock, if any, with respect to which this Warrant shall not then have
been exercised shall also be issued to the Holder hereof at the Issuer's expense
within such time.

         (e)  Transferability  of Warrant.  Subject to provisions  herein,  this
Warrant may be  transferred  by a Holder  without the consent of the Issuer.  If
transferred  pursuant  to  this  paragraph  and  subject  to the  provisions  of
subsection  (f) of this Section 2, this Warrant may be  transferred on the books
of the Issuer by the  Holder  hereof in person or by duly  authorized  attorney,
upon surrender of this Warrant at the principal  office of the Issuer,  properly
endorsed (by the Holder executing an assignment in the form attached hereto) and
upon payment of any necessary transfer tax or other governmental  charge imposed
upon such transfer.  This Warrant is exchangeable at the principal office of the
Issuer for Warrants for the purchase of the same  aggregate  number of shares of
Warrant  Stock,  each new Warrant to represent the right to purchase such number
of shares of Warrant Stock as the Holder  hereof shall  designate at the time of
such exchange.  All Warrants  issued on transfers or exchanges shall be dated as
of the Original Issue Date and shall be identical with this Warrant except as to
the name of the Holder or the number of shares of Warrant Stock, as applicable.

         (f) Continuing Rights of Holder.  The Issuer will, at the time of or at
any time after each  exercise  of this  Warrant,  upon the request of the Holder
hereof,  acknowledge in writing the extent, if any, of its continuing obligation
to afford to such  Holder all rights to which such Holder  shall  continue to be
entitled  after such  exercise  in  accordance  with the terms of this  Warrant,
provided  that if any such  Holder  shall  fail to make any  such  request,  the
failure shall not affect the continuing  obligation of the Issuer to afford such
rights to such Holder.

         (g) Compliance with Securities Laws.

                  (i)  The  Holder  of  this  Warrant,   by  acceptance  hereof,
         acknowledges  that this  Warrant or the  shares of Warrant  Stock to be
         issued upon exercise  hereof are being acquired solely for the Holder's
         own  account  and  not as a  nominee  for  any  other  party,  and  for
         investment,  and that the  Holder  will not  offer,  sell or  otherwise
         dispose of this  Warrant  or any  shares of Warrant  Stock to be issued
         upon  exercise  hereof  except  pursuant to an  effective  registration
         statement, or an exemption from registration,  under the Securities Act
         and any applicable state securities laws.

                  (ii) Except as provided in paragraph (iii) below, this Warrant
         and all certificates  representing  shares of Warrant Stock issued upon
         exercise  hereof  shall  be  stamped  or  imprinted  with a  legend  in
         substantially the following form:

             THIS WARRANT AND THE SHARES OF COMMON STOCK  ISSUABLE UPON EXERCISE
             HEREOF HAVE NOT BEEN  REGISTERED  UNDER THE SECURITIES ACT OF 1933,
             AS AMENDED (THE "SECURITIES  ACT") OR ANY STATE SECURITIES LAWS AND
             MAY NOT BE  SOLD,  TRANSFERRED  OR  OTHERWISE  DISPOSED  OF  UNLESS
             REGISTERED  UNDER THE  SECURITIES  ACT AND UNDER  APPLICABLE  STATE
             SECURITIES  LAWS OR PETCARE  TELEVISION  NETWORK,  INC.  SHALL HAVE
             RECEIVED AN OPINION OF COUNSEL  REASONABLY  SATISFACTORY TO MEDICAL
             MEDIA  TELEVISION,  INC. THAT REGISTRATION OF SUCH SECURITIES UNDER
             THE  SECURITIES  ACT AND UNDER THE  PROVISIONS OF APPLICABLE  STATE
             SECURITIES LAWS IS NOT REQUIRED.

                                       2
<PAGE>

                  (iii)  The   Issuer   agrees  to  reissue   this   Warrant  or
         certificates  representing any of the Warrant Stock, without the legend
         set forth  above if at such time,  prior to making any  transfer of any
         such  securities,  the Holder shall give  written  notice to the Issuer
         describing  the manner and terms of such  transfer  and  removal as the
         Issuer may reasonably request.  Such proposed transfer and removal will
         not be  effected  until:  (a) either (i) the  Issuer  has  received  an
         opinion of counsel reasonably satisfactory to the Issuer, to the effect
         that the  registration of such  securities  under the Securities Act is
         not  required  in  connection  with  such  proposed  transfer,  (ii)  a
         registration  statement under the Securities Act covering such proposed
         disposition  has been  filed by the  Issuer  with  the  Securities  and
         Exchange  Commission and has become effective under the Securities Act,
         (iii) the Issuer has received other evidence reasonably satisfactory to
         the  Issuer  that  such  registration  and   qualification   under  the
         Securities Act and state securities laws are not required,  or (iv) the
         Holder  provides  the  Issuer  with  reasonable  assurances  that  such
         security can be sold pursuant to Rule 144 under the Securities Act; and
         (b) either (i) the Issuer has received an opinion of counsel reasonably
         satisfactory  to  the  Issuer,  to  the  effect  that  registration  or
         qualification  under the  securities or "blue sky" laws of any state is
         not required in  connection  with such  proposed  disposition,  or (ii)
         compliance with applicable state securities or "blue sky" laws has been
         effected or a valid exemption exists with respect  thereto.  The Issuer
         will respond to any such notice from a holder  within five (5) business
         days.  In the case of any proposed  transfer  under this  Section,  the
         Issuer will use reasonable  efforts to comply with any such  applicable
         state securities or "blue sky" laws, but shall in no event be required,
         (x) to  qualify  to do  business  in any  state  where  it is not  then
         qualified,  (y) to take any action  that would  subject it to tax or to
         the  general  service  of  process  in any  state  where it is not then
         subject,  or (z) to comply with state  securities or "blue sky" laws of
         any state for which  registration by coordination is unavailable to the
         Issuer. The restrictions on transfer contained in this Section shall be
         in addition to, and not by way of limitation of, any other restrictions
         on transfer contained in any other section of this Warrant.

         (h) In no event may the  Holder  exercise  this  Warrant in whole or in
part unless the Holder is an  "accredited  investor" as defined in  Regulation D
under the Securities Act.

         3. Stock Fully Paid; Reservation and Listing of Shares; Covenants.

         (a) Stock Fully Paid. The Issuer  represents,  warrants,  covenants and
agrees that all shares of Warrant Stock which may be issued upon the exercise of
this Warrant or otherwise  hereunder  will,  when issued in accordance  with the
terms of this  Warrant,  be duly  authorized,  validly  issued,  fully  paid and
non-assessable  and free from all taxes, liens and charges created by or through
Issuer.  The Issuer  further  covenants and agrees that during the period within
which  this  Warrant  may be  exercised,  the  Issuer  will  at all  times  have
authorized  and  reserved  for the  purpose of the issue upon  exercise  of this
Warrant  a  sufficient  number of shares  of  Common  Stock to  provide  for the
exercise of this Warrant.

                                       3
<PAGE>

         (b) Reservation.  If any shares of Common Stock required to be reserved
for issuance  upon exercise of this Warrant or as otherwise  provided  hereunder
require registration or qualification with any governmental  authority under any
federal or state law before  such  shares may be so issued,  the Issuer  will in
good faith use its reasonable best efforts as  expeditiously  as possible at its
expense to cause such shares to be duly  registered or qualified.  If the Issuer
shall list any shares of Common  Stock on any  securities  exchange or market it
will, at its expense,  list thereon,  maintain and increase when  necessary such
listing,  of all shares of Warrant  Stock from time to time issued upon exercise
of this Warrant or as otherwise provided  hereunder  (provided that such Warrant
Stock  has been  registered  pursuant  to a  registration  statement  under  the
Securities  Act then in  effect),  and,  to the  extent  permissible  under  the
applicable securities exchange rules, all unissued shares of Warrant Stock which
are at any time issuable hereunder,  so long as any shares of Common Stock shall
be so  listed.  The  Issuer  will also so list on each  securities  exchange  or
market, and will maintain such listing of, any other securities which the Holder
of this  Warrant  shall be entitled to receive upon the exercise of this Warrant
if at the time  any  securities  of the  same  class  shall  be  listed  on such
securities exchange or market by the Issuer.

         (c) Covenants.  The Issuer shall not by any action  including,  without
limitation, amending the Articles of Incorporation or the by-laws of the Issuer,
or  through  any  reorganization,  transfer  of assets,  consolidation,  merger,
dissolution,  issue or sale of securities or any other action,  avoid or seek to
avoid the  observance or  performance  of any of the terms of this Warrant,  but
will at all times in good faith assist in the carrying out of all such terms and
in the taking of all such actions as may be necessary or  appropriate to protect
the rights of the Holder  hereof  against  dilution (to the extent  specifically
provided  herein)  or  impairment.   Without  limiting  the  generality  of  the
foregoing,  the Issuer will (i) not permit the par value,  if any, of its Common
Stock to exceed the then effective  Warrant Price,  (ii) not amend or modify any
provision  of the  Articles  of  Incorporation  or  by-laws of the Issuer in any
manner that would adversely  affect the rights of the Holders of the Warrants in
their capacity as Holders of the Warrants,  (iii) take all such action as may be
reasonably  necessary  in order that the Issuer may validly  and  legally  issue
fully  paid and  nonassessable  shares  of Common  Stock,  free and clear of any
liens,  claims,  encumbrances and  restrictions  (other than as provided herein)
upon the exercise of this Warrant,  and (iv) use its reasonable  best efforts to
obtain  all  such  authorizations,   exemptions  or  consents  from  any  public
regulatory body having  jurisdiction  thereof as may be reasonably  necessary to
enable the Issuer to perform its obligations under this Warrant.

         (d) Loss,  Theft,  Destruction  of  Warrants.  Upon receipt of evidence
satisfactory to the Issuer of the ownership of and the loss, theft,  destruction
or  mutilation  of any  Warrant  and,  in the  case of any such  loss,  theft or
destruction,  upon receipt of indemnity or security  satisfactory  to the Issuer
or, in the case of any such mutilation,  upon surrender and cancellation of such
Warrant,  the  Issuer  will  make and  deliver,  in lieu of such  lost,  stolen,
destroyed or mutilated Warrant, a new Warrant of like tenor and representing the
right to purchase the same number of shares of Common Stock.

         4. Adjustment of Warrant Price and Warrant Share Number.  The number of
shares of Common Stock for which this Warrant is  exercisable,  and the price at
which such  shares may be  purchased  upon  exercise of this  Warrant,  shall be
subject  to  adjustment  from time to time as set forth in this  Section  4. The
Issuer shall give the Holder notice of any event  described below which requires
an adjustment pursuant to this Section 4 in accordance with Section 5.

                                       4
<PAGE>

         (a) Recapitalization,  Reorganization, Reclassification, Consolidation,
Merger or Sale.

                  (i) In case the Issuer after the Original  Issue Date shall do
         any of the following (each, a "Triggering  Event"):  (a) consolidate or
         merge with or into another corporation where the holders of outstanding
         Voting Stock prior to such merger or  consolidation do not own over 50%
         of the outstanding  Voting Stock of the merged or  consolidated  entity
         immediately  after  such  merger or  consolidation,  or (b) sell all or
         substantially  all of its properties or assets to any other Person,  or
         (c) change the Common Stock to the same or  different  number of shares
         of  any  class  or  classes  of  stock,  whether  by  reclassification,
         exchange, substitution or otherwise (other than by way of a stock split
         or combination of shares or stock dividends or  distributions  provided
         for in  Section  4(b)  or  Section  4(c)),  or  (d)  effect  a  capital
         reorganization  (other than by way of a stock split or  combination  of
         shares or stock dividends or distributions provided for in Section 4(b)
         or Section 4(c)),  then, and in the case of each such Triggering Event,
         proper  provision  shall be made so that,  upon the basis and the terms
         and in the manner provided in this Warrant,  the Holder of this Warrant
         shall be  entitled  upon the  exercise  hereof  at any time  after  the
         consummation  of such  Triggering  Event, to the extent this Warrant is
         not exercised prior to such Triggering Event, to receive at the Warrant
         Price in effect at the time  immediately  prior to the  consummation of
         such  Triggering  Event in lieu of the Common Stock  issuable upon such
         exercise  of  this  Warrant  prior  to  such  Triggering   Event,   the
         securities,  cash and  property  to which such  Holder  would have been
         entitled upon the  consummation of such Triggering Event if such Holder
         had exercised the rights represented by this Warrant  immediately prior
         thereto,  subject to adjustments  (subsequent to such corporate action)
         as nearly  equivalent  as  possible  to the  adjustments  provided  for
         elsewhere in this Section 4.

                  (ii) Notwithstanding anything contained in this Warrant to the
         contrary,  a Triggering  Event shall not be deemed to have occurred if,
         prior to the consummation  thereof, each Person (other than the Issuer)
         which may be required to deliver any securities,  cash or property upon
         the  exercise  of this  Warrant as provided  herein  shall  assume,  by
         written  instrument  delivered to, and reasonably  satisfactory to, the
         Holder of this Warrant,  (A) the  obligations  of the Issuer under this
         Warrant  (and if the Issuer  shall  survive  the  consummation  of such
         Triggering  Event,  such assumption  shall be in addition to, and shall
         not release the Issuer from, any  continuing  obligations of the Issuer
         under this  Warrant) and (B) the  obligation  to deliver to such Holder
         such shares of securities,  cash or property as, in accordance with the
         foregoing  provisions  of this  subsection  (a),  such Holder  shall be
         entitled to receive,  and such Person shall have similarly delivered to
         such  Holder a written  acknowledgement  executed by the  President  or
         Chief Financial Officer of the Company, stating that this Warrant shall
         thereafter  continue  in full  force and  effect  and the terms  hereof
         (including,   without  limitation,   all  of  the  provisions  of  this
         subsection (a)) shall be applicable to the securities, cash or property
         which such Person may be required to deliver  upon any exercise of this
         Warrant or the exercise of any rights pursuant hereto.

         (b) Adjustments  for Issuance of Additional  Shares of Common Stock. In
the event the Company,  shall, at any time, from time to time, issue or sell any
additional shares of Common Stock or securities convertible into or exchangeable
for shares of Common Stock to a third party for a  consideration  per share less
than the Conversion  Price of the Note then in effect  immediately  prior to the
time of such issue or sale,  then,  forthwith  upon such  issuance or sale,  the
Conversion  Price  then in  effect  shall  be  reduced  to a price  equal to the
consideration  per share paid for such  securities.  Accordingly,  the  Exercise
Price  of the  Warrant  will be  adjusted  to  reflect  the same  percentage  of
reduction as in the Conversion Price adjustment.

         (c) Stock Dividends,  Subdivisions and Combinations. If at any time the
Issuer shall:

                           (i)  make  or  issue  or set a  record  date  for the
         holders  of its  Common  Stock for the  purpose  of  entitling  them to
         receive a dividend  payable  in, or other  distribution  of,  shares of
         Common Stock,

                           (ii) effect a stock split of its  outstanding  shares
         of Common Stock into a larger number of shares of Common Stock, or

                           (iii) combine its outstanding  shares of Common Stock
         into a smaller number of shares of Common Stock,

then (1) the  number  of  shares of Common  Stock  for  which  this  Warrant  is
exercisable immediately after the occurrence of any such event shall be adjusted
to equal the number of shares of Common Stock which a record  holder of the same
number of  shares  of  Common  Stock  for  which  this  Warrant  is  exercisable
immediately  prior to the  occurrence  of such event would own or be entitled to
receive  after the  happening of such event,  and (2) the Warrant  Price then in
effect  shall  be  adjusted  to  equal  (A) the  Warrant  Price  then in  effect
multiplied  by the number of shares of Common  Stock for which  this  Warrant is
exercisable  immediately  prior to the  adjustment  divided by (B) the number of
shares of Common Stock for which this Warrant is exercisable  immediately  after
such adjustment.

                                       5
<PAGE>

Notwithstanding  the  foregoing,  if such  record date shall have been fixed and
such dividend is not fully paid or if such distribution is not fully made on the
date fixed  therefor,  the  Warrant  Price  shall be  adjusted  pursuant to this
paragraph as of the time of actual payment of such dividends or distributions.

         (d) Certain Other  Distributions.  If at any time the Issuer shall make
or issue or set a record date for the determination of the holders of its Common
Stock for the  purpose  of  entitling  them to  receive  any  dividend  or other
distribution of:

              (i)   cash (other than a cash dividend  payable out of earnings or
                    earned  surplus   legally   available  for  the  payment  of
                    dividends   under   the   laws   of  the   jurisdiction   of
                    incorporation of the Issuer),

              (ii)  any  evidences of its  indebtedness,  any shares of stock of
                    any class or any other  securities or property of any nature
                    whatsoever  (other than cash,  Common Stock  Equivalents  or
                    Additional Shares of Common Stock), or

              (iii) any warrants or other  rights to  subscribe  for or purchase
                    any  evidences of its  indebtedness,  any shares of stock of
                    any class or any other  securities or property of any nature
                    whatsoever  (other than cash,  Common Stock  Equivalents  or
                    Additional Shares of Common Stock),

then (1) the  number  of  shares of Common  Stock  for  which  this  Warrant  is
exercisable  shall be  adjusted  to equal the product of the number of shares of
Common Stock for which this  Warrant is  exercisable  immediately  prior to such
adjustment  multiplied by a fraction (A) the numerator of which shall be the Per
Share Market Value of Common Stock at the date of taking such record and (B) the
denominator  of which  shall be such Per Share  Market  Value  minus the  amount
allocable to one share of Common Stock of any such cash so distributable  and of
the fair value (as  determined  in good faith by the Board of  Directors  of the
Issuer and supported by an opinion from an investment banking firm of recognized
national standing acceptable to (but not affiliated with) the Holder) of any and
all such  evidences  of  indebtedness,  shares of  stock,  other  securities  or
property or warrants or other  subscription or purchase rights so distributable,
and (2) the  Warrant  Price then in effect  shall be  adjusted  to equal (A) the
Warrant Price then in effect  multiplied by the number of shares of Common Stock
for which  this  Warrant  is  exercisable  immediately  prior to the  adjustment
divided  by (B) the number of shares of Common  Stock for which this  Warrant is
exercisable immediately after such adjustment.  A reclassification of the Common
Stock  (other  than a change in par value,  or from par value to no par value or
from no par value to par value)  into  shares of Common  Stock and shares of any
other class of stock shall be deemed a distribution by the Issuer to the holders
of its  Common  Stock of such  shares of such  other  class of stock  within the
meaning of this  Section  4(c) and, if the  outstanding  shares of Common  Stock
shall be changed into a larger or smaller  number of shares of Common Stock as a
part of such  reclassification,  such change  shall be deemed a  subdivision  or
combination,  as the case may be, of the  outstanding  shares  of  Common  Stock
within the meaning of Section 4(b).

Notwithstanding  the  foregoing,  if such  record date shall have been fixed and
such dividend is not fully paid or if such distribution is not fully made on the
date fixed  therefor,  the  Warrant  Price  shall be  adjusted  pursuant to this
Section  4(d)  as  of  the  time  of  actual   payment  of  such   dividends  or
distributions.

                                       6
<PAGE>

         (e) Purchase of Common  Stock by the Issuer.  If the Issuer at any time
while this  Warrant is  outstanding  shall,  directly  or  indirectly  through a
Subsidiary or  otherwise,  purchase,  redeem or otherwise  acquire any shares of
Common Stock at a price per share greater than the Per Share Market Value,  then
the Warrant Price upon each such purchase,  redemption or  acquisition  shall be
adjusted  to that  price  determined  by  multiplying  such  Warrant  Price by a
fraction (i) the numerator of which shall be the number of shares of Outstanding
Common Stock immediately prior to such purchase, redemption or acquisition minus
the number of shares of Common Stock which the aggregate  consideration  for the
total number of such shares of Common Stock so  purchased,  redeemed or acquired
would purchase at the Per Share Market Value;  and (ii) the denominator of which
shall be the number of shares of Outstanding Common Stock immediately after such
purchase,  redemption or acquisition.  For the purposes of this subsection,  the
date as of which the Per  Share  Market  Price  shall be  computed  shall be the
earlier of (x) the date on which the Issuer shall enter into a firm contract for
the purchase, redemption or acquisition of such Common Stock, or (y) the date of
actual  purchase,  redemption  or  acquisition  of such  Common  Stock.  For the
purposes of this subsection,  a purchase,  redemption or acquisition of a Common
Stock  Equivalent  shall be deemed to be a  purchase  of the  underlying  Common
Stock,  and the  computation  herein  required shall be made on the basis of the
full  exercise,  conversion  or exchange of such Common Stock  Equivalent on the
date as of which such computation is required hereby to be made,  whether or not
such  Common  Stock   Equivalent  is  actually   exercisable,   convertible   or
exchangeable on such date.

         (f) Other Provisions  applicable to Adjustments under this Section. The
following  provisions  shall be applicable to the making of  adjustments  of the
number of shares of Common Stock for which this Warrant is  exercisable  and the
Warrant Price then in effect provided for in this Section 4:

                  (i) Fractional Interests.  In computing adjustments under this
Section 4,  fractional  interests in Common Stock shall be taken into account to
the nearest one one-hundredth (1/100th) of a share.

                  (ii) When Adjustment Not Required.  If the Issuer shall take a
record of the holders of its Common Stock for the purpose of  entitling  them to
receive a dividend or distribution or subscription or purchase rights and shall,
thereafter and before the distribution to stockholders thereof,  legally abandon
its plan to pay or deliver such dividend, distribution, subscription or purchase
rights,  then thereafter no adjustment shall be required by reason of the taking
of such record and any such adjustment  previously made in respect thereof shall
be rescinded and annulled.

         (g) Form of Warrant  after  Adjustments.  The form of this Warrant need
not be changed because of any adjustments in the Warrant Price or the number and
kind of Securities purchasable upon the exercise of this Warrant.

         (h)  Escrow  of  Warrant   Stock.   If  after  any   property   becomes
distributable  pursuant to this  Section 4 by reason of the taking of any record
of the holders of Common  Stock,  but prior to the  occurrence  of the event for
which such record is taken, and the Holder exercises this Warrant, any shares of
Common Stock issuable upon exercise by reason of such adjustment shall be deemed
the  last  shares  of  Common   Stock  for  which  this   Warrant  is  exercised
(notwithstanding  any other provision to the contrary herein) and such shares or
other property shall be held in escrow for the Holder by the Issuer to be issued
to the Holder upon and to the extent that the event actually  takes place,  upon
payment of the current Warrant Price. Notwithstanding any other provision to the
contrary herein,  if the event for which such record was taken fails to occur or
is  rescinded,  then such  escrowed  shares shall be cancelled by the Issuer and
escrowed property returned.

                                       7
<PAGE>

         5. Notice of  Adjustments.  Whenever the Warrant Price or Warrant Share
Number  shall be adjusted  pursuant  to Section 4 hereof  (for  purposes of this
Section 5, each an  "adjustment"),  the Issuer  shall cause its Chief  Financial
Officer to prepare  and  execute a  certificate  setting  forth,  in  reasonable
detail,  the event requiring the adjustment,  the amount of the adjustment,  the
method by which such  adjustment was calculated  (including a description of the
basis on which the Board  made any  determination  hereunder),  and the  Warrant
Price and Warrant Share Number after giving effect to such adjustment, and shall
cause copies of such  certificate  to be delivered to the Holder of this Warrant
promptly after each adjustment. Any dispute between the Issuer and the Holder of
this Warrant with  respect to the matters set forth in such  certificate  may at
the option of the Holder of this  Warrant be  submitted  to one of the  national
accounting  firms  currently  known as the "big four"  selected  by the  Holder,
provided  that the Issuer shall have ten (10) days after  receipt of notice from
such Holder of its selection of such firm to object thereto,  in which case such
Holder shall select another such firm and the Issuer shall have no such right of
objection.  The firm  selected by the Holder of this  Warrant as provided in the
preceding  sentence shall be instructed to deliver a written  opinion as to such
matters to the Issuer and such Holder within  thirty (30) days after  submission
to it of such  dispute.  Such opinion  shall be final and binding on the parties
hereto.

         6.  Fractional  Shares.  No fractional  shares of Warrant Stock will be
issued in connection  with any exercise  hereof,  but in lieu of such fractional
shares,  the Issuer  shall make a cash payment  therefor  equal in amount to the
product of the applicable fraction multiplied by the Per Share Market Value then
in effect.

         7. Ownership Cap and Certain Exercise Restrictions.

                  (a) Notwithstanding anything to the contrary set forth in this
Warrant,  at no time may a Holder of this Warrant  exercise  this Warrant if the
number of shares of Common Stock to be issued  pursuant to such  exercise  would
exceed,  when  aggregated  with all other  shares of Common  Stock owned by such
Holder at such time,  the number of shares of Common Stock which would result in
such Holder  owning more than 4.999% of all of the Common Stock  outstanding  at
such time; provided,  however,  that upon a holder of this Warrant providing the
Issuer with  sixty-one  (61) days notice  (pursuant  to Section 13 hereof)  (the
"Waiver  Notice")  that such Holder  would like to waive this  Section 7(a) with
regard to any or all  shares of Common  Stock  issuable  upon  exercise  of this
Warrant, this Section 7(a) will be of no force or effect with regard to all or a
portion of the Warrant referenced in the Waiver Notice; provided,  further, that
this provision  shall be of no further force or effect during the sixty-one (61)
days immediately preceding the expiration of the term of this Warrant.

                  (b) The Holder may not exercise  the Warrant  hereunder to the
extent  such  exercise  would  result  in the  Holder  beneficially  owning  (as
determined  in  accordance  with Section 13(d) of the Exchange Act and the rules
thereunder)  in excess of 9.999% of the then  issued and  outstanding  shares of
Common Stock, including shares issuable upon exercise of the Warrant held by the
Holder after application of this Section; provided,  however, that upon a holder
of this  Warrant  providing  the Company  with a Waiver  Notice that such holder
would like to waive this Section 7(b) with regard to any or all shares of Common
Stock  issuable upon exercise of this Warrant,  this Section 7(b) shall be of no
force or effect with regard to those shares of Warrant  Stock  referenced in the
Waiver Notice;  provided,  further,  that this provision  shall be of no further
force or effect  during  the  sixty-one  (61)  days  immediately  preceding  the
expiration of the term of this Warrant.

         8. Registration  Rights.  Within one-hundred twenty (120) days from the
date of the Warrant,  the Company  shall file a  Registration  Statement on Form
SB-2 (or an alternative  available form) covering the underlying equity position
Warrant,  and the Company will keep said Registration  Statement effective for a
period of three years, subject to customary carve-outs.

                                       8
<PAGE>

         9. Definitions.  For the purposes of this Warrant,  the following terms
have the following meanings:

                  "Articles   of   Incorporation"    means   the   Articles   of
         Incorporation  of the Issuer as in effect on the  Original  Issue Date,
         and as hereafter from time to time amended,  modified,  supplemented or
         restated in  accordance  with the terms hereof and thereof and pursuant
         to applicable law.

                  "Board" shall mean the Board of Directors of the Issuer.

                  "Capital  Stock"  means and  includes  (i) any and all shares,
         interests,  participations  or other  equivalents  of or  interests  in
         (however designated)  corporate stock,  including,  without limitation,
         shares of preferred or preference stock, (ii) all partnership interests
         (whether  general or  limited)  in any Person  which is a  partnership,
         (iii) all membership  interests or limited  liability company interests
         in any  limited  liability  company,  and (iv) all equity or  ownership
         interests in any Person of any other type.

                  "Common  Stock" means the Common  Stock,  par value $.0005 per
         share,  of the Issuer and any other Capital Stock into which such stock
         may hereafter be changed.

                  "Convertible  Securities"  means  evidences  of  Indebtedness,
         shares of Capital Stock or other  Securities which are or may be at any
         time convertible  into or exchangeable for Additional  Shares of Common
         Stock.  The term  "Convertible  Security"  means one of the Convertible
         Securities.

                  "Exercise Price" means $2.40 per share.

                  "Governmental Authority" means any governmental, regulatory or
         self-regulatory   entity,   department,   body,  official,   authority,
         commission, board, agency or instrumentality, whether federal, state or
         local, and whether domestic or foreign.

                  "Holders" mean the Persons who shall from time to time own any
         Warrant. The term "Holder" means one of the Holders.

                  "Independent Appraiser" means a nationally recognized or major
         regional  investment  banking  firm or firm  of  independent  certified
         public  accountants of recognized  standing (which may be the firm that
         regularly  examines  the  financial  statements  of the Issuer) that is
         regularly  engaged in the business of  appraising  the Capital Stock or
         assets of corporations  or other entities as going concerns,  and which
         is not affiliated with either the Issuer or the Holder of any Warrant.

                  "Issuer"  means  Medical  Media  Television,  Inc.,  a Florida
         corporation, and its successors.

                  "Majority  Holders"  means at any time the Holders of Warrants
         exercisable  for a majority  of the shares of  Warrant  Stock  issuable
         under the Warrants at the time outstanding.

                  "Original Issue Date" means May 6, 2005.

                  "OTC  Bulletin  Board" means the  over-the-counter  electronic
         bulletin board.

                  "Other  Common" means any other Capital Stock of the Issuer of
         any class which shall be  authorized at any time after the date of this
         Warrant  (other  than  Common  Stock) and which shall have the right to
         participate  in the  distribution  of earnings and assets of the Issuer
         without limitation as to amount.

                                       9
<PAGE>

                  "Outstanding  Common  Stock"  means,  at any given  time,  the
         aggregate amount of outstanding  shares of Common Stock,  assuming full
         exercise,  conversion  or  exchange  (as  applicable)  of all  options,
         warrants and other Securities which are convertible into or exercisable
         or  exchangeable  for, and any right to subscribe for, shares of Common
         Stock that are outstanding at such time.

                  "Person" means an individual,  corporation,  limited liability
         company,  partnership,   joint  stock  company,  trust,  unincorporated
         organization,  joint venture, Governmental Authority or other entity of
         whatever nature.

                  "Per Share Market Value" means on any particular  date (a) the
         closing bid price for a share of Common  Stock in the  over-the-counter
         market,  as  reported  by the OTC  Bulletin  Board  or in the  National
         Quotation  Bureau  Incorporated  or  similar   organization  or  agency
         succeeding  to its  functions  of  reporting  prices)  at the  close of
         business on such date,  or (b) if the Common Stock is not then reported
         by the OTC Bulletin Board or the National Quotation Bureau Incorporated
         (or similar  organization  or agency  succeeding  to its  functions  of
         reporting prices),  then the average of the "Pink Sheet" quotes for the
         relevant  conversion period, as determined in good faith by the holder,
         or (c) if the Common Stock is not then publicly  traded the fair market
         value of a share of  Common  Stock as  determined  by the Board in good
         faith;  provided,  however, that the Majority Holders, after receipt of
         the determination by the Board, shall have the right to select, jointly
         with the Issuer,  an  Independent  Appraiser,  in which case,  the fair
         market value shall be the determination by such Independent  Appraiser;
         and provided,  further that all  determinations of the Per Share Market
         Value shall be appropriately  adjusted for any stock  dividends,  stock
         splits  or  other  similar   transactions   during  such  period.   The
         determination  of fair market value shall be based upon the fair market
         value of the Issuer  determined  on a going  concern basis as between a
         willing buyer and a willing seller and taking into account all relevant
         factors  determinative  of value, and shall be final and binding on all
         parties.  In determining  the fair market value of any shares of Common
         Stock, no consideration  shall be given to any restrictions on transfer
         of the  Common  Stock  imposed  by  agreement  or by  federal  or state
         securities  laws, or to the existence or absence of, or any limitations
         on, voting rights.

                  "Securities"  means  any  debt  or  equity  securities  of the
         Issuer, whether now or hereafter authorized, any instrument convertible
         into or  exchangeable  for  Securities  or a Security,  and any option,
         warrant or other right to purchase or acquire any Security.  "Security"
         means one of the Securities.

                  "Securities Act" means the Securities Act of 1933, as amended,
         or any similar federal statute then in effect.

                  "Subsidiary"  means  any  corporation  at  least  50% of whose
         outstanding  Voting  Stock  shall  at the  time be  owned  directly  or
         indirectly by the Issuer or by one or more of its  Subsidiaries,  or by
         the Issuer and one or more of its Subsidiaries.

                  "Term" has the meaning specified in Section 1 hereof.

                  "Trading  Day"  means (a) a day on which the  Common  Stock is
         traded on the OTC  Bulletin  Board,  or (b) if the Common  Stock is not
         traded on the OTC  Bulletin  Board,  a day on which the Common Stock is
         quoted in the  over-the-counter  market  as  reported  by the  National
         Quotation Bureau  Incorporated  (or any similar  organization or agency
         succeeding its functions of reporting prices); provided,  however, that
         in the event that the Common Stock is not listed or quoted as set forth
         in (a) or (b)  hereof,  then  Trading  Day  shall  mean any day  except
         Saturday, Sunday and any day which shall be a legal holiday or a day on
         which banking  institutions  in the State of New York are authorized or
         required by law or other government action to close.

                                       10
<PAGE>

                  "Voting  Stock" means,  as applied to the Capital Stock of any
         corporation, Capital Stock of any class or classes (however designated)
         having  ordinary  voting  power for the  election  of a majority of the
         members of the Board of  Directors  (or other  governing  body) of such
         corporation,  other than Capital Stock having such power only by reason
         of the happening of a contingency.

                  "Warrants" means this Warrant,  and any other warrants of like
         tenor issued in  substitution  or exchange for any thereof  pursuant to
         the  provisions of Section 2(c),  2(d) or 2(e) hereof or of any of such
         other Warrants.

                  "Warrant Share Number" means at any time the aggregate  number
         of shares of Warrant  Stock  which may at such time be  purchased  upon
         exercise of this Warrant,  after giving effect to all prior adjustments
         and  increases  to such  number  made or  required to be made under the
         terms hereof.

                  "Warrant  Stock" means Common Stock  issuable upon exercise of
         any Warrant or Warrants or otherwise  issuable  pursuant to any Warrant
         or Warrants.

         10. Other Notices. In case at any time:

                                  (A)   the Issuer shall make any  distributions
                                        to the holders of Common Stock; or

                                  (B)   the Issuer shall  authorize the granting
                                        to all  holders of its  Common  Stock of
                                        rights to subscribe  for or purchase any
                                        shares of Capital  Stock of any class or
                                        other rights; or

                                  (C)   there shall be any  reclassification  of
                                        the Capital Stock of the Issuer; or

                                  (D)   there     shall    be    any     capital
                                        reorganization by the Issuer; or

                                  (E)   there shall be any (i)  consolidation or
                                        merger  involving  the  Issuer  or  (ii)
                                        sale,  transfer or other  disposition of
                                        all or substantially all of the Issuer's
                                        property,  assets or business  (except a
                                        merger or other  reorganization in which
                                        the  Issuer   shall  be  the   surviving
                                        corporation  and its  shares of  Capital
                                        Stock shall  continue to be  outstanding
                                        and     unchanged     and    except    a
                                        consolidation, merger, sale, transfer or
                                        other     disposition     involving    a
                                        wholly-owned Subsidiary); or

                                  (F)   there   shall   be   a   voluntary    or
                                        involuntary dissolution,  liquidation or
                                        winding-up  of the Issuer or any partial
                                        liquidation    of    the    Issuer    or
                                        distribution to holders of Common Stock;

then, in each of such cases,  the Issuer shall give written notice to the Holder
of the date on which (i) the books of the Issuer  shall close or a record  shall
be taken for such dividend,  distribution  or  subscription  rights or (ii) such
reorganization,    reclassification,    consolidation,    merger,   disposition,
dissolution,  liquidation or  winding-up,  as the case may be, shall take place.
Such notice also shall  specify the date as of which the holders of Common Stock
of record shall  participate  in such  dividend,  distribution  or  subscription
rights, or shall be entitled to exchange their certificates for Common Stock for
securities   or   other   property   deliverable   upon   such   reorganization,
reclassification,  consolidation, merger, disposition,  dissolution, liquidation
or  winding-up,  as the case may be. Such notice  shall be given at least twenty
(20) days prior to the record date or effective date for the event  specified in
such notice.

                                       11
<PAGE>

         11. Amendment and Waiver. Any term, covenant, agreement or condition in
this  Warrant may be amended,  or  compliance  therewith  may be waived  (either
generally   or  in  a   particular   instance   and  either   retroactively   or
prospectively),  by a written instrument or written instruments  executed by the
Issuer and the Majority Holders;  provided,  however,  that no such amendment or
waiver  shall  reduce the Warrant  Share  Number,  increase  the Warrant  Price,
shorten the period  during  which this  Warrant may be  exercised  or modify any
provision of this Section 11 without the consent of the Holder of this Warrant.

         12.  Governing  Law. THIS WARRANT SHALL BE GOVERNED BY AND CONSTRUED IN
ACCORDANCE  WITH THE LAWS OF THE  STATE OF  FLORIDA  WITHOUT  GIVING  EFFECT  TO
PRINCIPLES OF CONFLICTS OF LAW.

         13. Notices.  Any and all notices or other communications or deliveries
required or permitted to be provided  hereunder shall be in writing and shall be
deemed given and  effective on the earlier of (i) the date of  transmission,  if
such  notice or  communication  is  delivered  via  facsimile  at the  facsimile
telephone  number  specified  for notice prior to 5:00 p.m.,  eastern time, on a
Trading Day, (ii) the Trading Day after the date of transmission, if such notice
or  communication  is delivered via facsimile at the facsimile  telephone number
specified for notice later than 5:00 p.m., eastern time, on any date and earlier
than 11:59 p.m., eastern time, on such date, (iii) the Trading Day following the
date  of  mailing,  if sent  by  overnight  delivery  by  nationally  recognized
overnight  courier  service  or (iv)  actual  receipt  by the party to whom such
notice is required to be given. The addresses for such  communications  shall be
with respect to the Holder of this Warrant or of Warrant  Stock issued  pursuant
hereto,  addressed to such Holder at its last known address or facsimile  number
appearing  on the books of the  Issuer  maintained  for such  purposes,  or with
respect to the Issuer, addressed to:

                  Medical Media Television, Inc.
                  8406 Benjamin Road, Suite C
                  Tampa, Florida 33634
                  Attention: Philip M. Cohen, President and CEO
                  Tel. No.: (813) 888-7330
                  Fax No.:  (813) 888-7375

Copies of  notices  to the Issuer  shall be sent to Bush Ross  Gardner  Warren &
Rudy, P.A., Attn: John N. Giordano, 220 S. Franklin Street, Tampa, FL 33601, Tel
No. (813)  224-9255,  Fax. No. (813)  224-9230.  Copies of notices to the Holder
shall be sent to Chris  Phillips,  MidTown  Partners & Co., LLC, 4902 Eisenhower
Blvd.,  Suite 185, Tampa,  Florida 33634. Any party hereto may from time to time
change its address for notices by giving at least ten (10) days  written  notice
of such changed address to the other party hereto.

         14. Warrant Agent.  The Issuer may, by written notice to each Holder of
this  Warrant,  appoint an agent having an office in New York,  New York for the
purpose  of issuing  shares of Warrant  Stock on the  exercise  of this  Warrant
pursuant to subsection (b) of Section 2 hereof, exchanging this Warrant pursuant
to  subsection  (d) of Section 2 hereof or replacing  this  Warrant  pursuant to
subsection (d) of Section 3 hereof, or any of the foregoing,  and thereafter any
such  issuance,  exchange or  replacement,  as the case may be, shall be made at
such office by such agent.

         15.  Remedies.  The Issuer  stipulates  that the remedies at law of the
Holder of this Warrant in the event of any default or threatened  default by the
Issuer in the performance of or compliance with any of the terms of this Warrant
are not and will not be adequate and that,  to the fullest  extent  permitted by
law,  such  terms may be  specifically  enforced  by a decree  for the  specific
performance  of any agreement  contained  herein or by an  injunction  against a
violation of any of the terms hereof or otherwise.

                                       12
<PAGE>

         16.  Successors  and  Assigns.  This  Warrant and the rights  evidenced
hereby  shall inure to the  benefit of and be binding  upon the  successors  and
assigns of the Issuer, the Holder hereof and (to the extent provided herein) the
Holders of Warrant Stock issued pursuant hereto, and shall be enforceable by any
such Holder or Holder of Warrant Stock.

         17.  Modification and Severability.  If, in any action before any court
or agency  legally  empowered to enforce any  provision  contained  herein,  any
provision  hereof is found to be  unenforceable,  then such  provision  shall be
deemed modified to the extent  necessary to make it enforceable by such court or
agency.  If any such provision is not  enforceable as set forth in the preceding
sentence,  the  unenforceability  of such  provision  shall not affect the other
provisions  of this  Warrant,  but this  Warrant  shall be  construed as if such
unenforceable provision had never been contained herein.

         18.  Headings.  The  headings of the  Sections of this  Warrant are for
convenience of reference  only and shall not, for any purpose,  be deemed a part
of this Warrant.

         IN WITNESS WHEREOF,  the Issuer has executed this Warrant as of the day
and year first above written.

                            MEDICAL MEDIA TELEVISION, INC.

                            By:  /s/ Philip M. Cohen
                                 -----------------------------------------------
                                 Philip M. Cohen
                                 President and Chief Executive Officer

                                       13
<PAGE>

                                  EXERCISE FORM

                         MEDICAL MEDIA TELEVISION, INC.

The  undersigned  _______________,  pursuant  to the  provisions  of the  within
Warrant, hereby elects to purchase _____ shares of Common Stock of Medical Media
Television, Inc. covered by the within Warrant.

Dated:                               Signature
       -------------------------               ---------------------------------
                                     Address
                                               ---------------------------------

                                               ---------------------------------

Number of shares of Common Stock beneficially owned or deemed beneficially owned
by the Holder on the date of Exercise: _________________________

                                   ASSIGNMENT

FOR VALUE RECEIVED,  _________________  hereby sells, assigns and transfers unto
__________________  the within Warrant and all rights evidenced thereby and does
irrevocably constitute and appoint _____________, attorney, to transfer the said
Warrant on the books of the within named corporation.

Dated:                               Signature
       -------------------------               ---------------------------------
                                     Address
                                               ---------------------------------

                                               ---------------------------------

                               PARTIAL ASSIGNMENT

FOR VALUE RECEIVED,  _________________  hereby sells, assigns and transfers unto
__________________  the right to  purchase  _________  shares of  Warrant  Stock
evidenced  by the within  Warrant  together  with all rights  therein,  and does
irrevocably  constitute and appoint  ___________________,  attorney, to transfer
that part of the said Warrant on the books of the within named corporation.

Dated:                               Signature
       -------------------------               ---------------------------------
                                     Address
                                               ---------------------------------

                                               ---------------------------------

                           FOR USE BY THE ISSUER ONLY:

This Warrant No. ___ canceled (or  transferred  or exchanged)  this _____ day of
___________,  _____,  shares  of Common  Stock  issued  therefor  in the name of
_______________,  Warrant No. ____ issued for ____ shares of Common Stock in the
name of _______________.Exhibit 10.7 - Debt Exchange Agreement with Pet Edge, LLC dated July 8, 2006.

                             DEBT EXCHANGE AGREEMENT

         This Debt Exchange Agreement (the "Agreement") dated as of July 8, 2005
is by and between  Medical  Media  Television,  Inc.  f/k/a  PetCARE  Television
Network,  Inc., a Florida corporation (the "Company"),  having a principal place
of business at 8406 Benjamin Road,  Suite C, Tampa,  Florida 33634 and Pet Edge,
LLC (the  "Lender")  having an address  at 36-16  Catoonah  Street,  Ridgefield,
Connecticut 06877.

         WHEREAS,  the Company has determined to enter into a  restructuring  of
its capital stock and outstanding indebtedness (the "Restructuring");

         WHEREAS,   the  Lender  is  the  holder  of  those  Senior  Convertible
Promissory Notes set forth on Schedule 1.2 attached hereto (the "Senior Notes");

         WHEREAS, pursuant to the Restructuring, the Lender has agreed to tender
its Senior Notes in exchange for, and the Company  desires to accept such tender
and issue in exchange,  shares of Series A Zero Coupon  Preferred  Stock, on the
terms  and   conditions   set  forth  in  this   Agreement  and,  as  additional
consideration,  the Company  desires to issue certain  warrants to the Lender to
purchase shares of its common stock, par value $.0005 (the "Common Stock").

         NOW,  THEREFORE,  in  consideration  of  the  foregoing,   and  of  the
representations,  warranties,  covenants and agreements  contained  herein,  and
intending  to be legally  bound  hereby,  the  parties  hereto  hereby  agree as
follows:

                                   ARTICLE 1

                                  THE EXCHANGE

         Section 1.1  Authorization of Series A Zero Coupon Preferred Stock. The
Company has authorized,  or shall authorize prior to the Closing,  the issue and
sale, in accordance  herewith,  of One million six hundred  eighty-two  thousand
forty-four  (1,682,044)  shares of its Series A Zero Coupon  Preferred Stock, no
par value per share (the "Series A Preferred  Stock"),  which Series A Preferred
Stock shall be issued  pursuant  to, and shall have the rights,  privileges  and
preferences set forth in, the Certificate of Designations  for the Series A Zero
Coupon   Preferred  Stock  in  the  form  of  Exhibit  A  attached  hereto  (the
"Certificate of Designations").

         Section 1.2 Transfer and Exchange.  Subject to and in  accordance  with
the terms and  conditions  of this  Agreement,  at the Closing  (as  hereinafter
defined), the Lender shall tender and deliver each of the Senior Notes set forth
on Schedule 1.2 to the Company for cancellation, and the Company shall issue and
deliver to the Lender (a) the number of shares of Series A  Preferred  Stock set
forth  opposite the Lender's name on Schedule 1.2 (the  "Exchanged  Shares") and
(b) the Warrants described in Section 1.3 below.

         Section 1.3 Issuance of Warrants.  On the terms and  conditions of this
Agreement,  at the Closing, the Company shall issue, transfer and deliver to the
Lender the  number of  warrants  to  purchase  shares of Common  Stock set forth
opposite the Lender's name on Schedule 1.2 (the "Warrants").  The Warrants shall
be in the form of Exhibit B attached hereto (the "Warrant Certificate").

<PAGE>

         Section 1.4 Deliveries at Closing. At the Closing (a) the Company shall
deliver to the Lender (i) one or more  certificates  representing  the Exchanged
Shares registered in the Lender's name (or its nominee),  duly authorized,  free
and clear of all liens and restrictions of any kind (except for those imposed by
the applicable  Certificate of Designations and applicable securities laws), and
(ii) one or more  Warrant  Certificates  representing  the  Warrants and (b) the
Lender  shall  deliver or cause to be  delivered to the Company the Senior Notes
held by the Lender  together  with all  documents  necessary to validly and duly
tender,  assign and convey  such Senior  Notes to the  Company for  cancellation
thereof.

         Section 1.5 Closing. The closing of the transactions  described in this
Agreement  shall take place at the offices of Bush Ross,  P.A.  220 S.  Franklin
Street,  Tampa,  Florida 33602 at 2:00 p.m., E.S.T., on July 8, 2005, or on such
other  business day thereafter as may be agreed to by the Company and the Lender
(such closing, the "Closing" and such date and time, the "Closing Date").

         Section 1.6 Cancellation of Senior Notes.  Upon receipt from the Lender
of the Senior Notes in  accordance  with Section 1.4 hereof,  the Company  shall
cancel each such Senior Note immediately.  The Company and the Lender agree that
upon such  cancellation of such Senior Notes: (a) the obligations of the Company
to pay the  principal  of,  interest on or  redemption  premium and otherwise in
respect of, such Senior  Notes  surrendered  by the Lender to the Company  shall
terminate;  (b) the  obligations  of the Company to pay any  interest  remaining
unpaid in respect of the Senior Notes shall  terminate,  and such interest shall
be deemed to have formed a portion of the  consideration  given for the purchase
of the Series A Preferred Stock by the Lender; (c) all obligations of the Lender
pursuant to the Senior Notes shall  terminate;  and (d) all  obligations  of the
Company in respect of the cancelled Senior Notes shall terminate.

         Section 1.7  Registration.  The Company  hereby  agrees to file, at its
sole cost and expense,  a registration  statement on Form S-4 (or an alternative
available  form  if the  Company  is not  eligible  to  file  a Form  S-4)  (the
"Registration  Statement") no later than forty five (45) days after the Closing,
registering  (a) all shares of Common  Stock  issuable  upon  conversion  of the
Series A  Preferred  Stock  and (b) all  shares of Common  Stock  issuable  upon
exercise of the Warrants.  The Company  hereby agrees to use its best efforts to
have the  Registration  Statement  declared  effective within one hundred twenty
(120) days after the Closing.

                                   ARTICLE 2

                  REPRESENTATIONS AND WARRANTIES OF THE COMPANY

         Section 2.1  Organization  and Authority.  The Company is a corporation
duly  organized,  validly  existing,  and in good standing under the laws of the
State of Florida. The Company has all requisite corporate power and authority to
execute  and  deliver  this  Agreement  and  to  consummate   the   transactions
contemplated hereby. All necessary action,  corporate or otherwise,  required to
have been taken by or on behalf of the Company by  applicable  law,  its charter
documents or otherwise to authorize (a) the approval,  execution and delivery on
behalf of the Company of this  Agreement and the  agreements,  certificates  and
other  documents  contemplated  hereby,  including,   without  limitation,   the
issuance,  sale and delivery of the Exchanged  Shares and the Warrants,  and (b)
the  performance  by  the  Company  of its  obligations  under  this  Agreement,
including,  without limitation, the issuance, sale and delivery of the Exchanged
Shares and the Warrants,  and the consummation of the transactions  contemplated
by  this  Agreement  hereof  has  been  taken,  other  than  the  filing  of the
Certificate  of  Designations,  which filing shall occur prior to Closing.  This
Agreement and the Warrant  Certificates  issued at the Closing  constitute valid
and  binding  agreements  of the  Company,  enforceable  against  the Company in
accordance with their respective terms, except (x) as the same may be limited by
applicable  bankruptcy,  insolvency,  moratorium  or  similar  laws  of  general
application  relating  to  or  affecting  creditors'  rights  and  (y)  for  the
limitations imposed by general principles of equity.

                                       2
<PAGE>

         Section 2.2 The  Exchanged  Shares.  Upon delivery to the Lender at the
Closing of certificates  representing the Exchanged Shares,  and upon receipt by
the Company of the Senior Notes in exchange  therefor,  (a) good and valid title
to such  Exchanged  Shares will pass to the Lender,  free and clear of all liens
and  restrictions  of any kind (except for those imposed by the  Certificate  of
Designations  and applicable  securities laws) and (b) the Exchanged Shares will
be duly authorized and validly issued, fully paid and nonassessable. The sale of
the  Exchanged  Shares  pursuant to this  Agreement is the only sale of Series A
Preferred Stock contemplated by the Company.

                                   ARTICLE 3

                  REPRESENTATIONS AND WARRANTIES OF THE LENDER

         Section  3.1  Investment  Representation.   The  Exchanged  Shares  and
Warrants are being acquired for the Lender's own account, for investment and not
with a view to, or for  resale in  connection  with,  a  distribution  or public
offering  thereof within the meaning of the  Securities Act or applicable  state
securities laws.

         Section 3.2 Transfer  Restrictions  under  Securities  Laws. The Lender
understands that none of the Exchanged Shares, Warrants or Common Stock issuable
upon exercise of the Warrants have been  registered  under the Securities Act of
1933, as amended (the "Securities Act"), or qualified under any state securities
laws. The Lender  understands that the resale of the Exchanged Shares,  Warrants
or Common  Stock  issuable  upon  exercise  of the  Warrants  may be  restricted
indefinitely  unless a subsequent  disposition  thereof is registered  under the
Securities Act and registered  under any state  securities law or is exempt from
such   registration.   Certificates   representing  the  Exchanged  Shares  (the
"Securities") shall be endorsed with the following legend, and any other legends
required by applicable securities laws:

         THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED
         UNDER THE  SECURITIES  ACT OF 1933,  AS AMENDED  (THE  "ACT"),  AND ARE
         "RESTRICTED  SECURITIES" AS DEFINED IN RULE 144  PROMULGATED  UNDER THE
         ACT.  THE  SECURITIES  MAY NOT BE SOLD OR OFFERED FOR SALE OR OTHERWISE
         DISTRIBUTED  EXCEPT (I) IN CONJUNCTION  WITH AN EFFECTIVE  REGISTRATION
         STATEMENT FOR THE SHARES UNDER THE ACT, OR (II) IN COMPLIANCE WITH RULE
         144 OR (III) OTHERWISE  PURSUANT TO AN EXEMPTION FROM THE  REGISTRATION
         REQUIREMENTS UNDER THE ACT.

The Company may instruct its transfer  agent not to register the transfer of the
Securities,  unless  the  conditions  specified  in  the  foregoing  legend  are
satisfied. The Warrants shall be endorsed with legends substantially in the form
set forth in the Warrant Certificates. Notwithstanding the foregoing, the Lender
may assign the Exchanged Shares, the Warrants and/or Common Stock to persons who
are members of PetEdge,  LLC who are  Accredited  Investors and who agree to the
terms of the restrictions contained in this Section.

         Section 3.3 Accredited  Investor  Status.  The Lender is an "Accredited
Investor" as that term is defined in Rule 501 of Regulation D promulgated  under
the  Securities  Act. The Lender is able to bear the economic  risk of acquiring
the  Exchanged  Shares and  Warrants  pursuant  to the terms of this  Agreement,
including a complete loss of the Lender's investment in the Exchanged Shares and
Warrants.

                                       3
<PAGE>

         Section  3.4  Organization  and  Authority.  The  Lender is a  company,
corporation or a partnership duly  incorporated,  organized,  or formed,  as the
case may be,  validly  existing and in good standing under the laws of the state
of its  incorporation,  organization or formation.  The Lender has all requisite
power and authority to execute and deliver this  Agreement and to consummate the
transactions  contemplated hereby. All necessary action, corporate or otherwise,
required to have been taken by or on behalf of the Lender by applicable law, its
charter  documents or otherwise to authorize  (a) the  approval,  execution  and
delivery  on behalf of it of this  Agreement  and (b) the  performance  by it of
obligations  under this  Agreement and the  agreements,  certificates  and other
documents   contemplated  hereby,  and  the  consummation  of  the  transactions
contemplated  hereby and thereby has been taken.  This  Agreement  constitutes a
valid and binding agreement of the Lender,  enforceable against it in accordance
with its terms.

         Section 3.5 No  Conflicts.  Neither the  execution and delivery of this
Agreement nor the consummation and performance of the transactions  contemplated
hereby to be  performed  or  satisfied  on the part of the Lender is  prevented,
limited  by,  conflicts  with,  or  will  result  in,  a  breach  of the  terms,
conditions, or provisions of any agreement to which the Lender is a party or any
law, rule, regulation, or order of any court or government agency.

         Section 3.6 Good Title to Senior Notes.  The Lender is the lawful owner
of the Senior  Notes set forth on  Schedule  1.2,  and the Lender has good title
thereto, free and clear of all liens, claims and encumbrances of any kind.

                                   ARTICLE 4

                                  MISCELLANEOUS

         Section 4.1 Binding  Effect;  Benefit.  This Agreement shall be binding
upon and shall inure to the benefit of the parties  hereto and their  respective
permitted  successors and assigns.  Notwithstanding  anything  contained in this
Agreement to the contrary,  nothing in this  Agreement,  express or implied,  is
intended  to  confer  on any  person  other  than the  parties  hereto  or their
respective permitted successors and assigns any rights, remedies, obligations or
liabilities under or by reason of this Agreement.

         Section  4.2  Entire  Agreement.   This  Agreement,  the  exhibits  and
schedules  hereto and any  documents  delivered  by the  parties  in  connection
herewith  constitute the entire  agreement among the parties with respect to the
subject  matter  hereof and supersede all prior  agreements  and  understandings
(oral and written) among the parties with respect thereto.

         Section 4.3  Governing  Law.  This  Agreement  shall be governed by and
construed in accordance  with the laws of the State of Florida without regard to
its rules of conflict of laws. Each of the parties hereto hereby irrevocably and
unconditionally  consents to submit to the exclusive  jurisdiction of the courts
of the State of Florida and of the United States of America located in the State
of Florida (the "Florida Courts") for any litigation  arising out of or relating
to this Agreement and the  transactions  contemplated  hereby (and agrees not to
commence any  litigation  relating  thereto  except in such courts),  waives any
objection to the laying of venue of any such  litigation  in the Florida  Courts
and  agrees not to plead or claim that such  litigation  brought in any  Florida
Court has been brought in an inconvenient forum.

         Section 4.4 Remedies; Specific Performance.  The Company and the Lender
may take all steps  necessary or  advisable to protect and enforce  their rights
hereunder,  whether by action,  suit or proceeding at law or in equity,  for the
specific  performance of any covenant,  condition or agreement contained herein,
or in aid of the execution of any power herein  granted,  or for the enforcement
of any other  appropriate  legal or equitable remedy or otherwise as the Company
or the Lender shall deem  necessary or advisable.  No right or remedy  hereunder
shall be exclusive of any other right,  power or remedy, but shall be cumulative
and in  addition  to any other  right or remedy  hereunder  or now or  hereafter
existing by law or in equity and the  exercise  by a party  hereto of any one or
more of such rights,  powers or remedies  shall not  preclude  the  simultaneous
exercise of any or all of such other rights, powers or remedies.  Any failure to
insist upon the strict  performance  of any provision  hereof or to exercise any
option, right, power or remedy contained herein shall not constitute a waiver or
relinquishment thereof for the future.

                                       4
<PAGE>

         Section 4.5 Counterparts. This Agreement may be executed by the parties
hereto in separate  counterparts,  each of which when so executed and  delivered
shall be an original,  but all such counterparts  shall together  constitute one
and the same instrument.

         Section 4.6  Headings.  Headings of the Sections of this  Agreement are
for the  convenience  of the parties only,  and shall be given no substantive or
interpretive effect whatsoever.

         Section  4.7  Interpretation.  In this  Agreement,  unless the  context
otherwise  requires,  words  describing  the singular  number shall  include the
plural and vice versa,  and words  denoting any gender shall include all genders
and words denoting  natural persons shall include  corporations and partnerships
and vice versa.

         Section 4.8  Incorporation of Exhibits and Schedules.  All exhibits and
schedules hereto are hereby  incorporated  herein and made a part hereof for all
purposes as if fully set forth herein.

         Section 4.9 Severability. Any term or provision of this Agreement which
is invalid or unenforceable in any jurisdiction  shall, as to that jurisdiction,
be  ineffective  to the extent of such  invalidity or  unenforceability  without
rendering  invalid or  unenforceable  the remaining terms and provisions of this
Agreement.

         Section 4.10  Attorneys'  Fees and Court Actions.  If a legal action is
initiated  by any party to this  Agreement  against  another,  arising out of or
relating  to  the  alleged  performance  or  non-performance  of  any  right  or
obligation  established  hereunder,  or any dispute concerning the same, any and
all fees, costs and expenses reasonably incurred by each prevailing party or its
legal counsel in investigating,  preparing for, prosecuting,  defending against,
or providing evidence, producing documents or taking any other action in respect
of, such action shall be the joint and several  obligation of, and shall be paid
or reimbursed by, the nonprevailing party.

         IN WITNESS  WHEREOF,  the Company and Lender have caused this Agreement
to be executed  and  delivered  by their  respective  officers,  thereunto  duly
authorized.

                                    MEDICAL MEDIA TELEVISION, INC.

                                    By: /s/ Philip M. Cohen
                                        ----------------------------------------
                                          Philip M. Cohen, President and CEO

                                    PET EDGE, LLC

                                    By: /s/ John Sfondrini
                                        ----------------------------------------
                                          John Sfondrini, Managing Director

                                       5
<PAGE>

                                  Schedule 1.2

                                  Senior Notes

<TABLE>
<CAPTION>
----------------------------------------------------------------------------------------------------------------------------
                                 Date of
                            Issuance/Original       Principal/Interest         Shares of Series A     Warrants to Purchase
                           Principal Amount of    Balance Outstanding as     Preferred Stock; Face      shares of Common
         Holder             Subordinated Note         of July 8 2005                 Value                    Stock
----------------------------------------------------------------------------------------------------------------------------
<S>                        <C>                    <C>                         <C>                     <C>
      PetEDGE, LLC           March 10, 2003
                               $1,000,000
----------------------------------------------------------------------------------------------------------------------------
      PetEDGE, LLC            May 28, 2003
                                 $50,000
----------------------------------------------------------------------------------------------------------------------------
      PetEDGE, LLC            June 6, 2003
                                 $50,000
----------------------------------------------------------------------------------------------------------------------------
      PetEDGE, LLC            July 1, 2003
                                $275,000
----------------------------------------------------------------------------------------------------------------------------
      PetEDGE, LLC                TOTAL                 $1,682,044                 1,682,044                2,102,556
----------------------------------------------------------------------------------------------------------------------------
</TABLE>

                                       6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00089-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00089-of-00352.parquet"}]]